ArticleBMC cancer2014

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.

Torsten Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.